专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2005048978A3 A CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION AND A PROCESS FOR PREPARING THE SAME 审中-公开
标题翻译：控制释放药物组合物及其制备方法
公开(公告)号：WO2005048978A3
公开(公告)日：2006-02-23
申请号：PCT/IN2004000306
申请日：2004-09-29
申请人： LUPIN LTD , SEN HIMADRI , JAYANTHI SURYAKUMAR , RAGHAVAN VINEETH , ARRA GANGA SRINIVAS
发明人： SEN HIMADRI , JAYANTHI SURYAKUMAR , RAGHAVAN VINEETH , ARRA GANGA SRINIVAS
IPC分类号： A61K9/00 , A61K9/24 , A61K9/20
CPC分类号： A61K9/209
摘要： A three-drug antiretrovial pharmaceutical composition having a selective combination of a controlled release active formulation and an immediate release active formulation for once daily administration. The composition provides desired dosages of the actives lamivudine, zidovudine or pharmaceutically acceptable derivatives thereof, and the immediate release formulation including at least one selective Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI), preferably nevirapine or a pharmaceutically acceptable derivative thereof along with pharmaceutically acceptable excipients. The once daily composition would favour patient compliance and effective treatment. A method of reducing the pill burden in a patient suffering from HIV infection and /or Acquired Immunodeffieciency Syndrome by administering a once daily dose of the three-drug antiretroviral pharmaceutical composition.
摘要翻译：一种三药抗逆转录药物组合物，其具有一次每日一次给药的控释活性制剂和立即释放活性制剂的选择性组合。所述组合物提供所需剂量的拉米夫定，齐多夫定或其药学上可接受的衍生物，以及即时释放制剂，其包含至少一种选择性非核苷逆转录酶抑制剂（NNRTI），优选奈韦拉平或其药学上可接受的衍生物以及药学上可接受的赋形剂。每天一次的组合将有利于患者的顺应性和有效的治疗。通过施用一日剂量的三药抗逆转录病毒药物组合物，减少患有HIV感染和/或获得性免疫缺陷综合征的患者的药丸负担的方法。

2. 发明专利

DE602004005734T2 未知
公开(公告)号：DE602004005734T2
公开(公告)日：2007-12-27
申请号：DE602004005734
申请日：2004-09-29
申请人： LUPIN LTD
发明人： SEN HIMADRI , JAYANTHI SURYAKUMAR , RAGHAVAN VINEETH , ARRA GANGA SRINIVAS
IPC分类号： A61K9/20 , A61K9/00 , A61K9/24
摘要： A three-drug antiretrovial pharmaceutical composition having a selective combination of a controlled release active formulation and an immediate release active formulation for once daily administration. The composition provides desired dosages of the actives lamivudine, zidovudine or pharmaceutically acceptable derivatives thereof, and the immediate release formulation including at least one selective Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI), preferably nevirapine or a pharmaceutically acceptable derivative thereof along with pharmaceutically acceptable excipients. The once daily composition would favour patient compliance and effective treatment. A method of reducing the pill burden in a patient suffering from HIV infection and/or Acquired Immunodeffieciency Syndrome by administering a once daily dose of the three-drug antiretroviral pharmaceutical composition.

3. 发明专利

ES2286716T3 COMPOSICION FARMACEUTICA DE LIBERACION CONTROLADA Y PROCESO PARA PREPARAR LA MISMA. 未知
公开(公告)号：ES2286716T3
公开(公告)日：2007-12-01
申请号：ES04817650
申请日：2004-09-29
申请人： LUPIN LTD
发明人： SEN HIMADRI , JAYANTHI SURYAKUMAR , RAGHAVAN VINEETH , ARRA GANGA SRINIVAS
IPC分类号： A61K9/20 , A61K9/00 , A61K9/24
摘要： Una composición farmacéutica antirretroviral que comprende una composición selectiva de i. una formulación de liberación controlada que comprende: a. lamivudina o un derivado farmacéuticamente aceptable de la misma, b. zidovudina o un derivado farmacéuticamente aceptable de la misma y c. una mezcla de polímeros hidrófilos seleccionados entre el grupo formado por éteres de celulosa, ácidos poliurónicos y gomas farmacéuticamente aceptables o mezclas de los mismos y d. una sal cálcica farmacéuticamente aceptable. ii. una formulación de liberación inmediata que comprende al menos un fármaco inhibidor no nucleósido de la transcriptasa inversa (INNTI) selectivo o un derivado farmacéuticamente aceptable del mismo, junto con excipientes farmacéuticamente aceptables.

4. 发明专利

EA008944B1 ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ УПРАВЛЯЕМОГО ВЫСВОБОЖДЕНИЯ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ 未知
公开(公告)号：EA008944B1
公开(公告)日：2007-10-26
申请号：EA200600679
申请日：2004-09-29
申请人： LUPIN LTD
发明人： SEN HIMADRI , JAYANTHI SURYAKUMAR , TAGHVAN VINEETH , ARRA GANGA SRINIVAS
IPC分类号： A61K9/20 , A61K9/00 , A61K9/24
摘要： Данноеизобретениекасаетсяантиретровируснойфармацевтическойкомпозицииизтрехлекарственныхпрепаратов, имеющейселективнуюкомбинациюактивногосоставауправляемоговысвобожденияи активногосоставанемедленноговысвобождениядляоднократногосуточноговведения. Композицияобеспечиваетнеобходимыедозыактивныхламивудина, зидовудинаилиихфармацевтическиприемлемыхпроизводныхи составанемедленноговысвобождения, включающегопоменьшеймереодинселективныйненуклеозидныйингибиторобратнойтранскриптазы (NNRTI), предпочтительноневирапинилиегофармацевтическиприемлемоепроизводноес фармацевтическиприемлемыминаполнителями. Однократнаясуточнаякомпозициябудетспособствоватьсоблюдениюпациентомрежимаприемалекарственногопрепаратаи эффективномулечению. Способснижаетлекарственнуюнагрузкунапациента, страдающегоинфекциейВИЧи/илисиндромомприобретенногоиммунногодефицита, введениемоднократнойсуточнойдозыантиретровируснойфармацевтическойкомпозицииизтрехлекарственныхпрепаратов.

5. 发明专利

MXPA06003479A UNA COMPOSICION FARMACEUTICA DE LIBERACION PROLONGADA Y UN PROCESO PARA SU PREPARACION. 未知
公开(公告)号：MXPA06003479A
公开(公告)日：2006-06-08
申请号：MXPA06003479
申请日：2004-09-29
申请人： LUPIN LTD
发明人： ARRA GANGA SRINIVAS
IPC分类号： A61K9/24 , A61K9/00
摘要： Una composicion farmaceutica antirretrovirica de tres farmacos que tiene una combinacion selectiva de una formulacion activa de liberacion prolongada y una formulacion activa de liberacion inmediata para administracion una vez al dia. La composicion proporciona dosificaciones deseadas de los ingredientes activos lamivudina, zidovudina o derivados farmaceuticamente aceptables de las mismas, la formulacion de liberacion inmediata incluye al menos un Inhibidor de Transcriptasa Inversa No Analogos de los Nucleosidos (NNRTI o Non-Nucleoside Reverse Transcriptase Inhibitors), de preferencia nevirapina o un derivado farmaceuticamente aceptable de la misma junto con excipientes farmaceuticamente aceptables. La composicion para administrarse una vez al dia favoreceria el cumplimiento del paciente y el tratamiento efectivo. Un metodo para disminuir la necesidad de tomar medicamentos en un paciente afectado con infeccion por VIH y/o Sindrome de Inmunodeficiencia Adquirida mediante la administracion de una dosis una vez al dia de la composicion farmaceutica antirretrovirica de tres farmacos.

6. 发明专利

DE602004005734D1 未知
公开(公告)号：DE602004005734D1
公开(公告)日：2007-05-16
申请号：DE602004005734
申请日：2004-09-29
申请人： LUPIN LTD
发明人： SEN HIMADRI , JAYANTHI SURYAKUMAR , RAGHAVAN VINEETH , ARRA GANGA SRINIVAS
IPC分类号： A61K9/20 , A61K9/00 , A61K9/24
摘要： A three-drug antiretrovial pharmaceutical composition having a selective combination of a controlled release active formulation and an immediate release active formulation for once daily administration. The composition provides desired dosages of the actives lamivudine, zidovudine or pharmaceutically acceptable derivatives thereof, and the immediate release formulation including at least one selective Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI), preferably nevirapine or a pharmaceutically acceptable derivative thereof along with pharmaceutically acceptable excipients. The once daily composition would favour patient compliance and effective treatment. A method of reducing the pill burden in a patient suffering from HIV infection and/or Acquired Immunodeffieciency Syndrome by administering a once daily dose of the three-drug antiretroviral pharmaceutical composition.

7. 发明专利

AT358470T 未知
公开(公告)号：AT358470T
公开(公告)日：2007-04-15
申请号：AT04817650
申请日：2004-09-29
申请人： LUPIN LTD
发明人： SEN HIMADRI , JAYANTHI SURYAKUMAR , RAGHAVAN VINEETH , ARRA GANGA SRINIVAS
IPC分类号： A61K9/00 , A61K9/24 , A61K9/20
摘要： A three-drug antiretrovial pharmaceutical composition having a selective combination of a controlled release active formulation and an immediate release active formulation for once daily administration. The composition provides desired dosages of the actives lamivudine, zidovudine or pharmaceutically acceptable derivatives thereof, and the immediate release formulation including at least one selective Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI), preferably nevirapine or a pharmaceutically acceptable derivative thereof along with pharmaceutically acceptable excipients. The once daily composition would favour patient compliance and effective treatment. A method of reducing the pill burden in a patient suffering from HIV infection and/or Acquired Immunodeffieciency Syndrome by administering a once daily dose of the three-drug antiretroviral pharmaceutical composition.

8. 发明专利

UA82564C2 АНТИРЕТРОВИРУСНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ЗАМЕДЛЕННОГО ВЫСВОБОЖДЕНИЯ И СПОСОБ ЕЕ ИЗГОТОВЛЕНИЯ 未知
公开(公告)号：UA82564C2
公开(公告)日：2008-04-25
申请号：UAA200604821
申请日：2004-09-29
申请人： LUPIN LTD
发明人： SEN HIMADRI , JAYANTHI SURYAKUMAR , RAGHAVAN VINEETH , ARRA GANGA SRINIVAS
IPC分类号： A61K9/22 , A61K9/00 , A61K9/24 , A61K31/505 , A61K31/551 , A61K31/7072 , A61K31/715 , A61K33/06 , A61P31/18
摘要： Изобретениеотноситсяк антиретровируснойфармацевтическойкомпозицииизтрехлекарственныхпрепаратов, обеспечивающейсочетаниезамедленногои немедленноговысвобождениядействующихингредиентов. Композицияобеспечиваетпоступлениетребуемыхдоздействующихингредиентовламивудина, зидовудинаилиихфармацевтическиприемлемыхпроизводных, атакженемедленноевысвобождениекакминимумодногоизбирательногоингибитораобратнойтранскриптазыненуклеозиднойприроды (NNRTI), предпочтительноневирапинаилиегофармацевтическиприемлемогопроизводногос фармацевтическиприемлемымивспомогательнымиингредиентами. Композициятребуетоднократногосуточногоприема, чтоспособствуетсоблюде

9. 发明专利

BRPI0415322A 未知
公开(公告)号：BRPI0415322A
公开(公告)日：2006-12-05
申请号：BRPI0415322
申请日：2004-09-29
申请人： LUPIN LTD
发明人： HIMADRI SEN , JAYANTHI SURYAKUMAR , RAGHAVAN VINEETH , ARRA GANGA SRINIVAS
IPC分类号： A61K9/00 , A61K9/24 , A61K9/20
摘要： A three-drug antiretrovial pharmaceutical composition having a selective combination of a controlled release active formulation and an immediate release active formulation for once daily administration. The composition provides desired dosages of the actives lamivudine, zidovudine or pharmaceutically acceptable derivatives thereof, and the immediate release formulation including at least one selective Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI), preferably nevirapine or a pharmaceutically acceptable derivative thereof along with pharmaceutically acceptable excipients. The once daily composition would favour patient compliance and effective treatment. A method of reducing the pill burden in a patient suffering from HIV infection and/or Acquired Immunodeffieciency Syndrome by administering a once daily dose of the three-drug antiretroviral pharmaceutical composition.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式